This PQI will discuss the use of oral avapritinib in patients with indolent systemic mastocytosis (ISM).
2027 NCODA Global Oncology & Haematology Congress
March 10, 2027 | 9:00 AM EST
Last Updated: December 10, 2025
Essentially, it’s a tool to improve patient care by sharing best practices in oncology care.
Consider this standardized, peer-review clinical guidance to oncology healthcare teams, enabling you and your team to consistently deliver high-quality care to your patients.
Find a PQI